SCHEMBL973003

SCHEMBL973003

Oc1ccc2cccc(O)c2n1.Oc1ccc2cccc(O)c2n1.Oc1ccc2cccc(O)c2n1.[Al]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.61
PLAU P00749 1/20 0.61
NCF1 P14598 1/20 0.61
ALOX12 P18054 3/20 0.59
ALDH1A1 P00352 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2C9 P11712 1/20 0.59
HPGD P15428 1/20 0.59
CYP2C19 P33261 1/20 0.59
HIF1A Q16665 1/20 0.59
HSD17B10 Q99714 1/20 0.59
KMT2A Q03164 7/20 0.55
KDM4E B2RXH2 5/20 0.55
SOS2 Q07890 1/20 0.55
TSHR P16473 2/20 0.54
MMP2 P08253 1/20 0.54
CHRM1 P11229 1/20 0.54
COMT P21964 1/20 0.54
ADRA1A P35348 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL672744 0.98 METAP2 (0.63) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL30082244 0.98 METAP2 (0.63) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL16444064 0.95 METAP2 (0.61) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL1496246 0.95 METAP2 (0.61) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL6540982 0.95 METAP2 (0.61) METAP2PLAUNCF1ALOX12ALDH1A1
Ammonia Solution, Strong SCHEMBL3284067 0.95 METAP2 (0.61) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL8467827 0.95 METAP2 (0.61) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL413180 0.95 METAP2 (0.61) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL15442576 0.95 METAP2 (0.61) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL7738434 0.95 METAP2 (0.61) METAP2PLAUNCF1ALOX12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 367 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1381096-B1 White organic light-emitting devices using a thin rubrene layer EASTMAN KODAK CO (US) 2008-10-01 EP claimed
EP-1187235-B1 White organic electroluminescent devices with improved stability and efficiency EASTMAN KODAK CO (US) 2007-07-18 EP claimed
EP-1286569-B1 White organic light-emitting devices with improved efficiency EASTMAN KODAK CO (US) 2007-06-06 EP claimed
US-6838193-B2 Organic light-emitting diode ACADEMIA SINICA (TW) 2005-01-04 US claimed
US-6720092-B2 DEVICE COMPRISING SUBSTRATE, ANODE, HOLE INJECTING LAYER, HOLE TRANSPORT LAYER, YELLOW LIGHT-EMITTING LAYER INCLUDING RUBRENE OR DERIVATIVE, LIGHT-EMITTING LAYER DOPED WITH BLUE LIGHT-EMITTING COMPOUND, ELECTRON TRANSPORT LAYER, CATHODE EASTMAN KODAK COMPANY 2004-04-13 US claimed
US-6696177-B1 HOLE AND ELECTRON TRANSPORT LAYERS; BLUE EMITTING LAYER SELECTIVELY DOPED WITH YELLOW EMITTING COMPOUND EASTMAN KODAK COMPANY 2004-02-24 US claimed
US-20040009367-A1 WHITE ORGANIC LIGHT-EMITTING DEVICES USING RUBRENE LAYER EASTMAN KODAK COMPANY 2004-01-15 US claimed
EP-1381096-A2 White organic light-emitting devices using rubrene layer EASTMAN KODAK COMPANY (US) 2004-01-14 EP claimed
US-6627333-B2 Diode obtained by doping yellow dopant in 4,4'-bis(N-(1-napthyl)-N-phenylamino)biphenyl hole transport layer, blue in t-butyl-9,10-di(2-naphthyl)anthracene emission layer, and green in tris(8-quinolinolato-N1,O8)aluminum transport layer EASTMAN KODAK COMPANY 2003-09-30 US claimed
US-20030068524-A1 White organic light-emitting devices with improved efficiency EASTMAN KODAK COMPANY 2003-04-10 US claimed
EP-1286569-A1 White organic light-emitting devices with improved efficiency EASTMAN KODAK COMPANY (US) 2003-02-26 EP claimed
EP-1187235-A2 White organic electroluminescent devices with improved stability and efficiency EASTMAN KODAK COMPANY (US) 2002-03-13 EP claimed
EP-1162674-A2 Organic electroluminescent devices with improved stability and efficiency EASTMAN KODAK COMPANY (US) 2001-12-12 EP claimed
US-6259203-B1 LUMINANCE IS NOT ATTENUATED IN LONG-TERM DRIVING VOLTAGE AND HAS GOOD DURABILITY; LAYERS OF AN ORGANIC COMPOUND SUCH AS 4,4?-BIS(2,2-DIPHENYLVINYL-1-YL)-P-TERT-PHENYLENE IDEMITSU KOSAN CO., LTD. (JP) 2001-07-10 US claimed
US-20230309389-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-28 US disclosed
US-20230200206-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 US disclosed
US-11678571-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 US disclosed
EP-0516409-A2 Tetravinylpyrazine compound, method for preparing same and electroluminescent element and non-linear optical material using same MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-12-02 EP disclosed
EP-0506368-A2 Organic functional thin film, fabrication and use thereof FUJITSU LIMITED (JP) 1992-09-30 EP disclosed
US-5122711-A Electroluminescent device PIONEER ELECTRONIC CORPORATION (JP) 1992-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230309389-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT EMITTING DEVICE CRY1, OCIAD1, ORC3 METAP2 4508/4885PLAU 4068/4885NCF1 425/4885
US-11678571-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle RPS17, RPS19, CDK17 METAP2 3844/4885PLAU 4366/4885NCF1 3737/4885
US-20230200206-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME MCM4, MCM2, CCNL2 METAP2 4695/4885PLAU 3269/4885NCF1 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.